An international comparison of the cost of fluid resuscitation therapies
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Australian Critical Care
- Vol. 34 (1) , 23-32
Abstract
No abstract availableKeywords
Funding Information
- CSL Behring
- Baxter Healthcare Corporation
This publication has 23 references indexed in Scilit:
- Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive CareNew England Journal of Medicine, 2012
- Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill AdultsJAMA, 2012
- Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe SepsisNew England Journal of Medicine, 2012
- Major Complications, Mortality, and Resource Utilization After Open Abdominal SurgeryAnnals of Surgery, 2012
- Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care unitsCritical Care, 2010
- Impact of albumin compared to saline on organ function and mortality of patients with severe sepsisIntensive Care Medicine, 2010
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisNew England Journal of Medicine, 2008
- Saline or Albumin for Fluid Resuscitation in Patients with Traumatic Brain InjuryNew England Journal of Medicine, 2007
- When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature*Critical Care Medicine, 2006
- A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care UnitNew England Journal of Medicine, 2004